Taiwan · Delayed Price · Currency is TWD Original BioMedicals Statistics
Total Valuation
TPEX:6483 has a market cap or net worth of TWD 1.01 billion. The enterprise value is 872.85 million.
| Market Cap | 1.01B |
| Enterprise Value | 872.85M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6483 has 66.59 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Current Share Class | 66.59M |
| Shares Outstanding | 66.59M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 14.97% |
| Owned by Institutions (%) | n/a |
| Float | 55.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,639.09 |
| PB Ratio | 6.37 |
| P/TBV Ratio | 6.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.60 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.00 |
Financial Position
The company has a current ratio of 9.74, with a Debt / Equity ratio of 0.07.
| Current Ratio | 9.74 |
| Quick Ratio | 9.37 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -177.28 |
Financial Efficiency
Return on equity (ROE) is -49.15% and return on invested capital (ROIC) is -29.97%.
| Return on Equity (ROE) | -49.15% |
| Return on Assets (ROA) | -28.22% |
| Return on Invested Capital (ROIC) | -29.97% |
| Return on Capital Employed (ROCE) | -62.60% |
| Weighted Average Cost of Capital (WACC) | 6.10% |
| Revenue Per Employee | 16,565 |
| Profits Per Employee | -4.41M |
| Employee Count | 23 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.40% in the last 52 weeks. The beta is 0.34, so TPEX:6483's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +20.40% |
| 50-Day Moving Average | 15.98 |
| 200-Day Moving Average | 13.39 |
| Relative Strength Index (RSI) | 45.29 |
| Average Volume (20 Days) | 256,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6483 had revenue of TWD 381,000 and -101.51 million in losses. Loss per share was -1.53.
| Revenue | 381,000 |
| Gross Profit | 306,000 |
| Operating Income | -104.60M |
| Pretax Income | -101.51M |
| Net Income | -101.51M |
| EBITDA | -99.88M |
| EBIT | -104.60M |
| Loss Per Share | -1.53 |
Balance Sheet
The company has 143.84 million in cash and 11.19 million in debt, with a net cash position of 132.65 million or 1.99 per share.
| Cash & Cash Equivalents | 143.84M |
| Total Debt | 11.19M |
| Net Cash | 132.65M |
| Net Cash Per Share | 1.99 |
| Equity (Book Value) | 157.84M |
| Book Value Per Share | 2.37 |
| Working Capital | 147.18M |
Cash Flow
In the last 12 months, operating cash flow was -96.01 million and capital expenditures -949,000, giving a free cash flow of -96.96 million.
| Operating Cash Flow | -96.01M |
| Capital Expenditures | -949,000 |
| Depreciation & Amortization | 4.72M |
| Net Borrowing | -4.33M |
| Free Cash Flow | -96.96M |
| FCF Per Share | -1.46 |
Margins
| Gross Margin | 80.31% |
| Operating Margin | -27,453.02% |
| Pretax Margin | -26,643.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6483 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.72% |
| Shareholder Yield | -0.72% |
| Earnings Yield | -10.10% |
| FCF Yield | -9.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6483 has an Altman Z-Score of 13.93 and a Piotroski F-Score of 2.
| Altman Z-Score | 13.93 |
| Piotroski F-Score | 2 |